Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

10x Genomics (TXG) Gross Profit (2018 - 2026)

10x Genomics' Gross Profit history spans 8 years, with the latest figure at $113.0 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 1.88% to $113.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $443.9 million, a 7.09% increase, with the full-year FY2025 number at $443.9 million, up 7.09% from a year prior.
  • Gross Profit hit $113.0 million in Q4 2025 for 10x Genomics, up from $100.3 million in the prior quarter.
  • Over the last five years, Gross Profit for TXG hit a ceiling of $125.1 million in Q2 2025 and a floor of $86.9 million in Q2 2022.
  • Historically, Gross Profit has averaged $104.0 million across 5 years, with a median of $102.5 million in 2021.
  • Biggest five-year swings in Gross Profit: surged 237.65% in 2021 and later fell 21.66% in 2022.
  • Tracing TXG's Gross Profit over 5 years: stood at $115.9 million in 2021, then grew by 3.0% to $119.4 million in 2022, then fell by 3.03% to $115.8 million in 2023, then decreased by 4.17% to $111.0 million in 2024, then rose by 1.88% to $113.0 million in 2025.
  • Business Quant data shows Gross Profit for TXG at $113.0 million in Q4 2025, $100.3 million in Q3 2025, and $125.1 million in Q2 2025.